Emma Zeta Limited, based in Cyprus, is part of the Emma Group, which is active in Romania, particularly in the energy sector (through the Premier Energy group) and in the gambling sector.
Diamedix Impex SA specializes in the marketing of a wide range of reagents and equipment for diagnostic techniques, the provision of on-site medical tests, with a focus on biochemistry and immunodiagnostics, food and feed testing, including allergens, and the provision of specialized equipment for medical imaging, including ultrasound, mammography and medical printers.
“Following the analysis, the Competition Council found that this operation does not raise significant obstacles to effective competition on the Romanian market or on a substantial part of it and there are no serious doubts as to its compatibility with a normal competitive environment. The decision will be published on the website of the national competition authority, after the removal of confidential information,” the Competition Council said in a press statement.
Investment fund GED, the leading actor in the financial investors segment in Romania about 15-20 years ago, sold Diamedix to Emma Capital, the last of which owns in Romania, among others, Premier Energy (stock symbol: PE), one of the largest natural gas suppliers in Romania.
Data on online platform www.termene.ro show that Diamedix is 80%-owned by GED and 20% by Vasileios Chrelias. GED became a shareholder in Diamedix in 2009. Throughout the years, GED’s portfolio also included travel agency Happy Tour, InfoPress (typography), as well as other companies it sold.
Diamedix ended 2023 with a turnover of RON265 million, up 16% against 2022.